Bio Usawa Biotechnology and Bioeq AG Partner to Create Widespread Access to Vision-Saving Medicine Across Sub-Saharan AfricaLandmark partnership will democratize access to critical eye treatment for millions facing preventable blindness from diabetes complications
Bio Usawa and Pacific Environmental Technologies Announce Landmark Partnership to Develop and Deploy Modular cGMP Biomanufacturing Units for AfricaA pioneering monoclonal antibody facility for Rwanda marks a pivotal step toward scalable, locally driven production of life-saving biologics across the African continent
Bio Usawa Appoints Dr. Patrick Lukulay as Chief Operating OfficerSAN FRANCISCO and KIGALI, Rwanda, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Bio Usawa, Inc., a pioneering biotechnology company dedicated to developing high-quality, affordable monoclonal antibodies in Africa, appointed Dr. Patrick Lukulay as its Chief Operating Officer.
Bio Usawa Names Former Ghana Food and Drug Authority Director Eric Karikari-Boateng as Head of Global Regulatory StrategySAN FRANCISCO and KIGALI, Rwanda, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Bio Usawa, Inc., a leading biotechnology company committed to delivering affordable and accessible monoclonal antibody-based therapies for cancer, ophthalmic, autoimmune, and infectious diseases in Africa, has named Mr. Eric Karikari-Boateng its Head of Global Regulatory Strategy.
